Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


Crystax Pharmaceuticals and Uriach sign a contract for new anti-inflammatory drug development

Biotech company Crystax Pharmaceuticals and Uriach Laboratories have come to an agreement for the development of new anti-inflammatory drugs. The research contract between the companies, with headquarters in the Barcelona Science Park, establishes the structure determination of a target protein by X-ray crystallography and the later molecular screening for hit-to-lead candidates.

Crystax is a pioneering firm in the Spanish biotech market focused in structure determination technology. Uriach is a pharma company established in 1838 with a wide presence in Spain.

Publisher Contact Information:

Crystax Pharmaceuticals S.L.
+34 934034787

Company profile of Crystax Pharmaceuticals S.L.
Past press releases of Crystax Pharmaceuticals S.L..


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Nov 25€24.0MInternet commerce
Feb 21€87.0MInternet services
Feb 21€18.0MInternet commerce
Feb 20€4.3MSoftware development
Feb 19€0.4MInternet commerce
Feb 19€8.4MMedical devices
Feb 18€25.0MBiotechnology

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Jan 29
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.